Resilience, positive coping, and quality of life among women newly diagnosed with gynecological cancers

Por Manne, Sharon, Myers-Virtue, Shannon, Kashy, Deborah, Ozga, Melissa, Kissane, David, Heckman, Carolyn, Rubin, Stephen C., Rosenblum, Norman
Publicado no Cancer Nurs (2015)

Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma

Por Zhang, Lin, Yang, Nuo, Conejo Garcia, Jose-Ramon, Mohamed, Alisha, Benencia, Fabian, Rubin, Stephen C., Allman, David, Coukos, George
Publicado em 2002

Intraepithelial T Cells and Tumor Proliferation: Impact on the Benefit from Surgical Cytoreduction in Advanced Serous Ovarian Cancer

Por Adams, Sarah F., Levine, Douglas A., Cadungog, Mark G., Hammond, Rachel, Facciabene, Andrea, Olvera, Narciso, Rubin, Stephen C., Boyd, Jeff, Gimotty, Phyllis A., Coukos, George
Publicado em 2009

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

Por Adams, Sarah F., Marsh, Evelyn B., Elmasri, Wafic, Halberstadt, Steffanie, VanDecker, Stephanie, Sammel, Mary D., Bradbury, Angela R., Daly, Mary, Karlan, Beth, Rubin, Stephen C.
Publicado em 2011

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritonea...

Por Dizon, Don S., Sill, Michael W., Gould, Natalie, Rubin, Stephen C., Yamada, S. Diane, DeBernardo, Robert L., Mannel, Robert S., Eisenhauer, Eric L., Duska, Linda R., Fracasso, Paula M.
Publicado em 2011

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton...

Por Behbakht, Kian, Sill, Michael W., Darcy, Kathleen M., Rubin, Stephen C., Mannel, Robert S., Waggoner, Steven, Schilder, Russell J., Cai, Kathy Q., Godwin, Andrew K., Alpaugh, R. Katherine
Publicado em 2011

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary perito...

Por Morgan, Mark A., Sill, Michael W., Fujiwara, Keiichi, Greer, Benjamin, Rubin, Stephen C., DeGeest, Koen, Yamada, S. Diane, Waggoner, Steven, Coleman, Robert L., Walker, Joan L., Mannel, Robert S
Publicado em 2011

Tissue-based immune monitoring I: Tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment

Por Hagemann, Andrea R, Cadungog, Mark, Hagemann, Ian S, Hammond, Rachel, Adams, Sarah F, Chu, Christina S, Rubin, Stephen C, Zhang, Lin, Addya, Kathakali, Birrer, Michael J, Gimotty, Phyllis A, Coukos, George
Publicado em 2011

BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Tewari, Krishnansu S., Sill, Michael W., Coleman, Robert L., Aghajanian, Carol, Mannel, Robert, DiSilvestro, Paul A., Powell, Matthew, Randall, Leslie M., Farley, John, Rubin, Stephen C., Monk, Bradley J.
Publicado no Gynecol Oncol (2020)

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

Por DeMichele, Angela, Troxel, Andrea B., Berlin, Jesse A., Weber, Anita L., Bunin, Greta R., Turzo, Elene, Schinnar, Rita, Burgh, Desiree, Berlin, Michelle, Rubin, Stephen C., Rebbeck, Timothy R., Strom, Brian L.
Publicado em 2008

Tissue-based immune monitoring II: Multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma

Por Hagemann, Andrea R, Hagemann, Ian S, Cadungog, Mark, Hwang, Wei-Ting, Patel, Priya, Lal, Priti, Hammond, Rachel, Gimotty, Phyllis A, Chu, Christina S, Rubin, Stephen C, Birrer, Michael J, Powell, Daniel J, Feldman, Michael D, Coukos, George
Publicado em 2011

Correlation between Surgeon’s assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cyt...

Por Eskander, Ramez N, Kauderer, James, Tewari, Krishnansu S, Mannel, Robert S, Bristow, Robert E, O’Malley, David M, Rubin, Stephen C, Glaser, Gretchen E, Hamilton, Chad A, Fujiwara, Keiichi, Huh, Warner K, Ueland, Frederick, Stephan, Jean-Marie, Burger, Robert A
Publicado no Gynecol Oncol (2018)

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Por Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Publicado em 2014

CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: an ACRIN and GOG study

Por Ng, Chaan S, Zhang, Zheng, Lee, Susanna I, Marques, Helga S, Burgers, Kyle, Su, Feng, Bauza, Joseph, Mannel, Robert S, Walker, Joan L, Huh, Warner King, Rubin, Stephen C, DiSilvestro, Paul, Martin, Lainie P, Chan, John K, Bookman, Michael A, Coleman, Robert L, Lee, Ting-Yim
Publicado no Clin Cancer Res (2017)

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0...

Por Coleman, Robert L, Brady, Mark F, Herzog, Thomas J, Sabbatini, Paul, Armstrong, Deborah K, Walker, Joan L, Kim, Byoung-Gie, Fujiwara, Keiichi, Tewari, Krishnansu S, O'Malley, David M, Davidson, Susan A, Rubin, Stephen C, DiSilvestro, Paul, Basen-Engquist, Karen, Huang, Helen, Chan, John K, Spirtos, Nick M, Ashfaq, Raheela, Mannel, Robert S
Publicado no Lancet Oncol (2017)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Por Walker, Joan L., Brady, Mark F., Wenzel, Lari, Fleming, Gini F., Huang, Helen Q., DiSilvestro, Paul A., Fujiwara, Keiichi, Alberts, David S., Zheng, Wenxin, Tewari, Krishnansu S., Cohn, David E., Powell, Matthew A., Van Le, Linda, Davidson, Susan A., Gray, Heidi J., Rose, Peter G., Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C., Mannel, Robert S.
Publicado no J Clin Oncol (2019)